List of Tables
Table 1. Alzheimer's Disease Drug Market Trends
Table 2. Alzheimer's Disease Drug Market Drivers & Opportunity
Table 3. Alzheimer's Disease Drug Market Challenges
Table 4. Alzheimer's Disease Drug Market Restraints
Table 5. Global Alzheimer's Disease Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Alzheimer's Disease Drug Revenue Market Share by Company (2019-2024)
Table 7. Global Alzheimer's Disease Drug Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Alzheimer's Disease Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Alzheimer's Disease Drug Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Alzheimer's Disease Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Alzheimer's Disease Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Alzheimer's Disease Drug
Table 13. Global Alzheimer's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Alzheimer's Disease Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Alzheimer's Disease Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Alzheimer's Disease Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Alzheimer's Disease Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Alzheimer's Disease Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Alzheimer's Disease Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Alzheimer's Disease Drug Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Alzheimer's Disease Drug Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Alzheimer's Disease Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Alzheimer's Disease Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Alzheimer's Disease Drug Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Alzheimer's Disease Drug Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Alzheimer's Disease Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Alzheimer's Disease Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Alzheimer's Disease Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Alzheimer's Disease Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Alzheimer's Disease Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Alzheimer's Disease Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Alzheimer's Disease Drug Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Alzheimer's Disease Drug Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Alzheimer's Disease Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Alzheimer's Disease Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Alzheimer's Disease Drug Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Alzheimer's Disease Drug Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Alzheimer's Disease Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Alzheimer's Disease Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Alzheimer's Disease Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Alzheimer's Disease Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global Alzheimer's Disease Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global Alzheimer's Disease Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Alzheimer's Disease Drug Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Alzheimer's Disease Drug Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Alzheimer's Disease Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global Alzheimer's Disease Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global Alzheimer's Disease Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Alzheimer's Disease Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Alzheimer's Disease Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Alzheimer's Disease Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Alzheimer's Disease Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Alzheimer's Disease Drug Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Alzheimer's Disease Drug Sales Volume, (2025-2030) & (K Units)
Table 57. Allergan Company Information
Table 58. Allergan Introduction and Business Overview
Table 59. Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Allergan Alzheimer's Disease Drug Product Offerings
Table 61. Allergan Recent Development
Table 62. Eisai Company Information
Table 63. Eisai Introduction and Business Overview
Table 64. Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Eisai Alzheimer's Disease Drug Product Offerings
Table 66. Eisai Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Introduction and Business Overview
Table 69. Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Novartis Alzheimer's Disease Drug Product Offerings
Table 71. Novartis Recent Development
Table 72. Daiichi Sankyo Company Information
Table 73. Daiichi Sankyo Introduction and Business Overview
Table 74. Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Daiichi Sankyo Alzheimer's Disease Drug Product Offerings
Table 76. Daiichi Sankyo Recent Development
Table 77. Merz Pharma Company Information
Table 78. Merz Pharma Introduction and Business Overview
Table 79. Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Merz Pharma Alzheimer's Disease Drug Product Offerings
Table 81. Merz Pharma Recent Development
Table 82. Pfizer Company Information
Table 83. Pfizer Introduction and Business Overview
Table 84. Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Pfizer Alzheimer's Disease Drug Product Offerings
Table 86. Pfizer Recent Development
Table 87. Johnson & Johnson Company Information
Table 88. Johnson & Johnson Introduction and Business Overview
Table 89. Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Johnson & Johnson Alzheimer's Disease Drug Product Offerings
Table 91. Johnson & Johnson Recent Development
Table 92. Lundbeck Company Information
Table 93. Lundbeck Introduction and Business Overview
Table 94. Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Lundbeck Alzheimer's Disease Drug Product Offerings
Table 96. Lundbeck Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Alzheimer's Disease Drug Downstream Customers
Table 100. Alzheimer's Disease Drug Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Alzheimer's Disease Drug Product Picture
Figure 2. Global Alzheimer's Disease Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Alzheimer's Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Alzheimer's Disease Drug Sales Volume (2019-2030) & (K Units)
Figure 5. Global Alzheimer's Disease Drug Sales Price (2019-2030) & (USD/Unit)
Figure 6. Alzheimer's Disease Drug Report Years Considered
Figure 7. Global Alzheimer's Disease Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Alzheimer's Disease Drug Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Alzheimer's Disease Drug Revenue in 2023
Figure 10. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Donepezil Picture
Figure 12. Memantine Picture
Figure 13. Rivastigmine Picture
Figure 14. Others Picture
Figure 15. Global Alzheimer's Disease Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Alzheimer's Disease Drug Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Alzheimer's Disease Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Alzheimer's Disease Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Alzheimer's Disease Drug Price by Type (2019-2030) & (USD/Unit)
Figure 20. Product Picture of Early to Moderate Stages
Figure 21. Product Picture of Moderate to Severe Stages
Figure 22. Global Alzheimer's Disease Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Alzheimer's Disease Drug Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Alzheimer's Disease Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Alzheimer's Disease Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Alzheimer's Disease Drug Price by Application (2019-2030) & (USD/Unit)
Figure 27. North America Alzheimer's Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Alzheimer's Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Alzheimer's Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Alzheimer's Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Alzheimer's Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Alzheimer's Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Alzheimer's Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Alzheimer's Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Alzheimer's Disease Drug Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Alzheimer's Disease Drug Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Alzheimer's Disease Drug Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Alzheimer's Disease Drug Sales Volume (%), (2019-2030)
Figure 39. United States Alzheimer's Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Alzheimer's Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Alzheimer's Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Alzheimer's Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Alzheimer's Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Alzheimer's Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 45. China Alzheimer's Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Alzheimer's Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 47. China Alzheimer's Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Alzheimer's Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Alzheimer's Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Alzheimer's Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Alzheimer's Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Alzheimer's Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Alzheimer's Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Alzheimer's Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Alzheimer's Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Alzheimer's Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 57. India Alzheimer's Disease Drug Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Alzheimer's Disease Drug Sales Value by Type (%), 2023 VS 2030
Figure 59. India Alzheimer's Disease Drug Sales Value by Application (%), 2023 VS 2030
Figure 60. Alzheimer's Disease Drug Industrial Chain
Figure 61. Alzheimer's Disease Drug Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
